FlandersBio on Twitter

Follow us on Twitter

Archive for November 2009 - News

Archive for November 2009 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

FORMAC appoints new CEO

30.11.2009

FORMAC Pharmaceuticals N.V., a Belgian-based drug delivery and development company, today announced that as of January 1, 2010 Jan Rosier will become the company’s new Chief Executive Officer (CEO), replacing Laurens G. Theunis. read more

Galapagos receives EUREKA innovation label and OSEO funding

26.11.2009

Galapagos NV (Euronext: GLPG) announces that its antibody therapeutics program with MorphoSys and SARM program have been awarded funding by the French governmental organization OSEO. Accordingly, the Paris-based Galapagos R&D center will receive interest free loans from OSEO worth €1.2 M over the next two years. read more

Agfa HealthCare to acquire European contrast media company Insight Agents

26.11.2009

Agfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, announces today that it has signed an agreement with Curagita Holding AG to acquire all the shares of its subsidiary Insight Agents GmbH. read more

Philips agrees to sell FIMI to Barco of Belgium

25.11.2009

Royal Philips Electronics (AEX: PHI, NYSE: PHG) today announced it has reached an agreement to sell the shares of FIMI to leading display technology company Barco NV (EURONEXT: BAR) headquartered in Kortrijk, Belgium. FIMI is a medical display provider that is currently part of Philips’ Healthcare business. read more

Devgen & Leads Agri announce the launch of MasuwerteTM, Devgen's first hybrid rice seed product for the Philippines

25.11.2009

Devgen (Euronext Brussels; DEVG) and Leads Agri today announced the launch of the first Devgen hybrid rice seed product MasuwerteTM for the Philippines. MasuwerteTM is a high yielding long grain hybrid rice, with a good aroma. read more

Labo voor Parasitologie van de UGent erkend als WHO-partner

24.11.2009

Dit artikel is verschenen op Medinews.be.
Klik hier voor het volledige artikel. read more

Agfa HealthCare Drives Innovation in Healthcare IT With Launch of Institute in Canada

24.11.2009

Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, today introduced the Agfa HealthCare Institute - a new initiative leveraging collaborative partnerships with world-class vendors, academic institutions, government and healthcare providers throughout North America to help facilitate innovation in the healthcare technology space. read more

Ablynx receives €1.1 million grant to further develop new routes of administration for nanobodies®

23.11.2009

Ablynx [Euronext Brussels: ABLX], announced today that it has been awarded a grant worth €1.1 million by the Flemish agency for Innovation by Science and Technology (IWT). read more

Movetis obtains EU authorisation for the commercialisation of Resolor® (prucalopride)

22.11.2009

Movetis, the GI specialty pharmaceutical company based in Belgium, announces that it has obtained approval from the European Commission for the commercialisation of its lead product Resolor (prucalopride – a 1mg and 2mg once a day oral tablet) for the symptomatic treatment of chronic constipation (CC) in women in whom laxatives fail to provide adequate relief. read more

Movetis seeking up to 112.4 million euros in IPO

20.11.2009

Belgian drugmaker Movetis said it could raise up to 112.4 million euros ($167 million) in an initial public offering to help fund the European launch of its Resolor treatment for chronic constipation in women. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top

Print